Fecal Microbiota Therapy, Live-Jslm Improves HRQOL In Patients With Recurrent CDI, Research Suggests

August 16, 2023

Infectious Disease Advisor (8/15, Chan) reports that a study suggests “patients receiving biotherapeutic therapy with fecal microbiota, live-jslm for recurrent Clostridioides difficile infection experience substantial and sustained improvement in disease-...